EN DE
Watch Transpek Industry Limited for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Transpek Industry Limited (506687) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Transpek Industry Limited stock ₹1,176, price ₹1,360, that is 13.5% below the price, quality 61 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Materials IN

TI Transpek Industry Limited logo Broad data Nov 16, 2026

Transpek Industry Limited

506687 · BSE

Expensive (fair value 14% below the price), but solid company and rising price: meets 2 of 3 rules.

Follow free in the weekly email
Quality 61/100 
Rising price (uptrend) 
Solidly profitable · 11.9% net margin (TTM) 
Low debt 
Generates free cash flow 
0.2% dividend yield · Well covered
Ranks above peers (10/14) 
Broad data 
Moderate moat 59/100 · thin data
Revenue last quarter 38% below a year ago. 
Fair value ₹1,176 · Overvalued 
Weak Growth (revenue 3y −9.1 %/yr in INR) 
⟳ Cyclical
Watch Transpek Industry Limited for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹2,408 ₹876.30 Fair Value ₹1,176 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range ₹876.30 – ₹2,408 · fair‑value band ₹785.96 – ₹1,575 · the ₹1,360 price screens above the ₹1,176 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Transpek Industry in your weekly email

Every Wednesday you see whether Transpek Industry is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Transpek Industry Limited manufactures and sells chemical products in India.

Show moreShow less

The company offers 2, 4, 6 trimethyl benzoyl chloride, 2-chloroethylamine hydrochloride solution, 2-ethylhexanoyl chloride, 2-methoxyethyl chloride, 2-propoxyethyl chloride, 4-chlorobutyryl chloride, cocoyl chloride, diethylene glycol dichloride, isobutyryl chloride, isononanoyl chloride, isophthaloyl chloride, and lauroyl chloride.

It also provides m-nitrobenzoyl chloride, methoxyacetyl chloride, n-butyryl chloride, n-decanoyl chloride, n-octyl chloride, n-valeroyl chloride, neodecanoyl chloride, o-toluoyl chloride, octanoyl chloride, p-nitrobenzoyl chloride, pivaloyl chloride, propargyl chloride solution, sulphur dichloride, sulphur monochloride, terephthaloyl chloride, triethyleneglycol dichloride, and thionyl chloride.

The company serves customers in various industries, including textiles, pharmaceuticals, agrochemicals, advanced polymers, etc. Transpek Industry Limited also exports its products. The company was founded in 1965 and is headquartered in Vadodara, India.

Stock analysis

Transpek Industry Limited (506687) currently trades at ₹1,360, while our model-based Fair Value estimate is ₹1,176, 14% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of ₹1,389 per share, and 7 of the 26 models we run sit above the ₹1,360 price.

Bear case: the Asset-Based group reads lowest at ₹171.27, and 19 of the 26 models stay below the price. Data coverage for this calculation is high.

Scenario range: ₹785.96 (bear) to ₹1,575 (bull), the price of ₹1,360 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 61/100 (solid quality), in the Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Transpek Industry Limited reported revenue of ₹6.2B in FY2026 versus ₹6.0B in FY2022, a compound +0.9%/yr. Reported net income was ₹456M in FY2026, compounding −8.6%/yr from FY2022.

Key figures

Market cap ₹10.7B (≈ $115M) Micro · P/E ratio 11.5 · P/S ratio 1.36 · EPS (TTM) ₹104.67 · Dividend yield 0.2% · Net margin 11.9% · Return on equity 17.5% · Return on assets (EBIT) 7.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 59 out of 100 (low confidence).

What moves the price

The share trades about 5% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Materials peers we cover trades at −44% fair-value upside, at −14%, 506687 screens cheaper than that median.

Fair Value models

Bear ₹785.96 Fair Value ₹1,176 Bull ₹1,575
Price ₹1,360 · Downside -13.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹64.94 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹713.55 ₹997.29 ₹1,363 81
Growth DCF ₹706.23 ₹957.06 ₹1,260 79
Owner Earnings ₹732.56 ₹1,025 ₹1,402 77
All 26 models by family
DCF Models
FCF DCF ₹713.55 ₹997.29 ₹1,363 81
Owner Earnings ₹732.56 ₹1,025 ₹1,402 77
5Y Revenue Exit ₹744.96 ₹1,155 ₹1,689 72
5Y EBITDA Exit ₹975.51 ₹1,608 ₹2,372 74
5Y P/E Exit ₹872.13 ₹1,405 ₹1,986 70
10Y Revenue Exit ₹703.80 ₹1,032 ₹1,494 67
10Y EBITDA Exit ₹840.24 ₹1,293 ₹1,934 68
10Y P/E Exit ₹785.96 ₹1,176 ₹1,686 64
Earnings-Based
Graham-Dodd ₹555.70 ₹2,178 ₹2,956 64
Lynch FV ₹658.24 ₹940.34 ₹1,222 61
PEG = 1.0 ₹658.24 ₹940.34 ₹1,222 57
EPV ₹359.70 ₹390.23 ₹414.55 74
Dividend Discount
Gordon GGM ₹127.44 ₹202.90 ₹253.89 69
DDM Multi-Stage ₹127.44 ₹197.22 ₹219.15 67
Multiples
P/E Multiple ₹1,042 ₹1,389 ₹1,737 63
P/S Multiple ₹1,042 ₹1,389 ₹1,737 58
P/B Multiple ₹3,091 ₹4,122 ₹5,152 55
EV/EBIT ₹776.59 ₹1,057 ₹1,337 66
EV/EBITDA ₹1,189 ₹1,607 ₹2,025 67
EV/Revenue ₹664.43 ₹976.87 ₹1,289 53
Asset-Based
NCAV (Graham) ₹113.04 ₹171.27 ₹214.09 54
Growth DCF
Growth DCF ₹706.23 ₹957.06 ₹1,260 79
Rev-Margin DCF ₹744.96 ₹1,153 ₹1,653 72
Economic Profit
Residual Income ₹931.04 ₹902.95 ₹933.60 76
ROIC Compounder ₹359.70 ₹390.23 ₹414.55 72
Growth Earnings
Growth-Adj P/E ₹848.30 ₹1,212 ₹1,575 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 61/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 46
Are margins and returns getting better?
Cashflow 49
Do the profits arrive as real cash?
Financial strength 68
Debt, balance sheet and risk of trouble
Investment 69
Does it invest with discipline instead of growing at any price?
Low Volatility 69
How calm the share price moves, does not count
Price momentum 62
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 58
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
Start year 2021 (pandemic). Over 10 years: +8.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.9%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.9% vs 4.3%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 7%
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+16.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +11.6% a year for the price.

506687 screens overvalued: fair value 14% below the price. Compare with Linde plc →

Compare Transpek Industry Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 758 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 61 · Above median
Fair Value upside −13.5% · Above median
Profitability
Return on equity (12 months) 17.5% · Top 25%
Return on assets 4.5% · Above median
Net margin (12 months) 11.9% · Top 25%
Operating margin (12 months) 17.5% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) −37.5% · Bottom 25%
Dividend yield (12 months) 0.2% · Bottom 25%
Balance sheet
Debt / equity 0.02× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 11.5× · Cheapest 25%
P/B 1.40× · Cheaper than median
P/S (12 months) 2.18× · Pricier than median
Price / free cash flow (fiscal year) 26.7× · Pricier than median
EV/EBITDA 9.8× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)15 · sector 7
FUTURE (revenue growth)0 · sector 70
PAST (return on equity)70 · sector 26
HEALTH (low debt)99 · sector 95
DIVIDEND (yield)4 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.18 ¥68.03 −2% vs 506687
Linde plc LIN $515.11 $446.62 −13% vs 506687
PPG Industries, Inc PPG $120.82 $77.68 −36% vs 506687
DSM-Firmenich AG DSFIR CHF 96.00 CHF 58.32 −39% vs 506687
Asian Paints Limited ASIANPAINT ₹2,625 ₹1,479 −44% vs 506687
The Sherwin-Williams Company SHW $344.15 $152.59 −56% vs 506687
Givaudan SA GIVN CHF 4,072 CHF 1,618 −60% vs 506687
EMS-CHEMIE HOLDING AG EMSN CHF 836.00 CHF 284.63 −66% vs 506687
Ecolab Inc ECL $302.59 $97.18 −68% vs 506687
Air Products and Chemicals, Inc APD $306.92 $75.33 −75% vs 506687

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Transpek Industry Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Transpek Industry Limited Fair Value". https://www.fairvalue-calculator.com/stock/506687

Frequently asked questions

Is Transpek Industry Limited (506687) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of ₹1,176 versus a price of ₹1,360, about 14% lower (overvalued).
What is the fair value of 506687?
Our model-based fair value for Transpek Industry Limited is ₹1,176 (as of Nov 16, 2026), built from audited fundamentals. The current price: ₹1,360.
What is the quality score of 506687?
Transpek Industry Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Transpek Industry Limited (506687)?
Our model-based price target is the fair value of ₹1,176 (as of Nov 16, 2026) from 26 valuation models. Cautious scenario ₹785.96, optimistic scenario ₹1,575. It is a calculation from audited fundamentals, not an analyst target.
What is the Transpek Industry Limited stock forecast for 2026?
Our models put fair value at ₹1,176, about 14% lower versus a price of ₹1,360 (overvalued). Cautious scenario ₹785.96, optimistic scenario ₹1,575. The calculation is refreshed regularly with new filings.
What is the revenue of Transpek Industry Limited (506687)?
Transpek Industry Limited reported trailing-twelve-month revenue of about ₹4.9B (latest available figure, as of Nov 16, 2026).
Does Transpek Industry Limited pay a dividend?
Transpek Industry Limited currently shows a dividend yield of 0.18% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of Transpek Industry Limited (506687)?
Transpek Industry Limited pays a dividend of ₹2.50 per share a year, a dividend yield of 0.2%. A dividend has been paid every year since 2013. The payout ratio is 2.4% of earnings. Free cash flow covers the dividend 28.81 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Transpek Industry Limited (506687)?
For today's price to be fair in a discounted-cash-flow model, Transpek Industry Limited would have to grow free cash flow by 16.3 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 12.9 % per year. As of Nov 16, 2026.
What discount rate (WACC) does the fair value of 506687 use?
Our models discount Transpek Industry Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.14, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Transpek Industry Limited that is +16.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Transpek Industry Limited (506687) delivered so far?
Over the past 5 years revenue at Transpek Industry Limited grew 12.9 % a year. The price currently implies free-cash-flow growth of +16.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Transpek Industry Limited (506687) growing?
The median revenue growth in the sector is +11.6 % a year. That is the yardstick for the growth priced into Transpek Industry Limited (+16.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Transpek Industry Limited (506687)?
The free-cash-flow yield on the price is 5.30 %: that much free cash flow Transpek Industry Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Transpek Industry Limited (506687)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Transpek Industry Limited it is ₹1,176 per share (as of Nov 16, 2026), against a price of ₹1,360. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Transpek Industry Limited stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 506687 trades above its calculated fair value: price ₹1,360, fair value ₹1,176, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 506687?
No. The price is what the market pays today (₹1,360); the fair value is what the company's own numbers justify (₹1,176). For Transpek Industry Limited the two are ₹183.99 per share apart. That gap is exactly why we show both numbers side by side.
How much is Transpek Industry Limited worth?
The market values Transpek Industry Limited at about ₹10.7B (market capitalisation, as of Nov 16, 2026). Per share that is ₹1,360; our models calculate a fair value of ₹1,176 per share.
What do the bullish and bearish scenarios say about 506687?
Our models span a range for Transpek Industry Limited: cautious scenario ₹785.96, base ₹1,176, optimistic ₹1,575 per share (as of Nov 16, 2026, price ₹1,360). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 506687?
Transpek Industry Limited trades at a price-to-earnings ratio of 11.5 (as of Nov 16, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹1,176 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings: 13.5. Other multiples: P/B 1.4, P/S 2.2, EV/EBITDA 9.8.
How solid is the balance sheet of Transpek Industry Limited (506687)?
Balance-sheet figures for Transpek Industry Limited (as of Nov 16, 2026): return on equity 17.5%, debt of 0.02 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is 506687 from its 52-week high?
Transpek Industry Limited trades at ₹1,360, about 5% below its 52-week high of ₹1,436 and 55% above the low of ₹876.30 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of ₹1,176 is for.
Which stocks are comparable to Transpek Industry Limited?
From the same area (Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Transpek Industry Limited stock attractive at the current price?
The data as of Nov 16, 2026: price ₹1,360, calculated fair value ₹1,176 (−14%), Quality Score 61/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 506687 calculated?
We run Transpek Industry Limited through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹1,176 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. Transpek Industry Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Transpek Industry Limited (506687)?
The closing price on Nov 17, 2026 was ₹1,360. Our model-based fair value is ₹1,176, about 14% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Transpek Industry Limited right now?
Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹785.96 to ₹1,575) leaves room in how you read the outcome.

Key figures of Transpek Industry Limited

How large is the market capitalisation of Transpek Industry Limited (506687)?
The market capitalisation of Transpek Industry Limited is ₹10.7B (≈ $115M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Transpek Industry Limited (506687)?
The price-to-sales ratio of Transpek Industry Limited is 1.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Transpek Industry Limited (506687)?
Earnings per share at Transpek Industry Limited are ₹104.67 (price ÷ EPS = P/E 11.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Transpek Industry Limited (506687)?
The dividend yield of Transpek Industry Limited is 0.2% (payout 2.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Transpek Industry Limited (506687)?
The net margin of Transpek Industry Limited is 11.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Transpek Industry Limited (506687)?
The return on equity (ROE) of Transpek Industry Limited is 17.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Transpek Industry Limited (506687)?
On an EBIT basis the return on assets of Transpek Industry Limited is 7.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Transpek Industry Limited (506687)?
The operating margin of Transpek Industry Limited is 17.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Transpek Industry Limited (506687)?
Revenue at Transpek Industry Limited is down 37.5% versus a year earlier (3y avg −9.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Transpek Industry Limited (506687)?
Earnings per share at Transpek Industry Limited are down 96.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Transpek Industry Limited (506687) carry?
The net debt of Transpek Industry Limited is ₹361M (fiscal year 2024, ≈ 0.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Transpek Industry Limited in the live analysis

One click puts Transpek Industry Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.